Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
January 11 2021 - 08:24AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of January 2021
Commission
File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
On
January 11, 2021, Medigus Ltd. issued a press release titled: “Medigus Prices $8.4 Million Underwritten Public Offering
of American Depositary Shares.” A copy of this press release is furnished herewith as Exhibit 99.1 and incorporated herein
by reference.
EXHIBIT
INDEX
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS LTD.
|
|
|
|
Date:
January 11, 2021
|
By:
|
/s/
Tatiana Yosef
|
|
|
Tatiana
Yosef
|
|
|
Chief Financial Officer
|
3
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2023 to Mar 2024